If Democrat Joe Biden is successful in his bid for the presidency but the Senate remains in GOP control, Democrats’ plans for major changes in health care may be curbed.
As the votes continue to be counted in the tight battle between President Donald Trump and former Vice President Joe Biden, the federal role in health care is at stake.
Voters in Montana, Nebraska, South Dakota and several other conservative-leaning states will decide in November whether to legalize medical or recreational marijuana.
American marijuana has a reputation for being the best in the world. But the federal prohibition on marijuana makes shipments across state lines or overseas a pipe dream. While U.S. firms expect the restrictions to drop in the coming years, they are stuck operating within state borders. That’s left Canadian cannabis growers to dominate the export market, with U.S. firms falling further behind each year.
After the state legalized recreational marijuana in 2016, new taxes and regulations decimated an ad hoc network that had donated cannabis for medical purposes to patients who could not afford it. A recent law seeks to revive the network, but hurdles remain.
A Navy veteran from Cleveland tried vaping marijuana to deal with his chronic pain. He landed in the hospital, becoming one of over 2,400 Americans who have suffered serious lung injury from vaping.
The latest Democratic debate did not dwell on “Medicare for All,” despite strong divisions among the presidential candidates.
Surgeon General Jerome Adams said the drug has a “unique impact” on the developing brain — technically true, but neglecting a vital comparison to other drugs, as well as shortcomings in the existing research.
Many cases of vaping-related injury seem to involve THC, health officials say. That’s led some states to take another look at the safety of the regulated cannabis market, as well as the black market.
A seedy section of downtown Los Angeles has become the go-to place for those who trade in wholesale — and sometimes counterfeit — vaping products. As more people fall ill with a mysterious lung disease linked to e-cigarette use, the manufacture and distribution of vaping products face increased scrutiny.